Description
KSQ-4279 is an inhibitor of the deubiquitinating enzyme USP1.
| Product Unit Size | Cost | Quantity | Stock |
|---|
KSQ-4279 is an inhibitor of the deubiquitinating enzyme USP1.
| Cas No. | 2446480-97-1 |
|---|---|
| Purity | ≥98% |
| Formula | C27H25F3N8O |
| Formula Wt. | 534.55 |
| IUPAC Name | 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine |
| Synonym | USP1-IN-1; KSQ4279 |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Cadzow L, Brenneman J, Sullivan P, et al. Development of KSQ-4279 as a first-in-class USP1 inhibitor for the treatment of BRCA-deficient cancers. Eur J Cancer. 2020 Oct 1;138(Supplement 2,S52).
Cadzow L, Tobin E, Sullivan P, et al. Abstract ND01: KSQ-4279: A first-in-class USP1 inhibitor for the treatment of cancers with homologous recombination deficiencies. Cancer Res. 2022;82(12_Supplement):ND01.
Immunomodulator; teratogen.
Arp2/3 inhibitor.
Microtubule polymerization inhibitor.
Thienylbutyl ITC analog.
SHP2 inhibitor
L-type Ca2+ channel blocker.
Organosulfur, chelating agent.
BRD4 inhibitor.
Polyene macrolide; ergosterol inhibitor.
5-HT3 antagonist.
MEK1/2 inhibitor.
PI3K and mTOR inhibitor.
Derivative of methyl caffeate, hydroxycinnamic ...
Terpene found in various plant and fruit source...
Taxol synthesis intermediate.
Pyrimidine nucleoside (cytidine) analog; DNA ch...
NSAID; TREK1 K+ potentiator, voltage-gated Na+ ...
SERM.
BHA derivative.
Lincosamide; ribosomal translocation and protei...